Single User License
INR 161350
Site License
INR 322700
Corporate User License
INR 484050

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Nicotine Addiction Global Clinical Trials Review, H1, 2015

Nicotine Addiction Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2574CTIDB
  • |
  • Pages: 81
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Nicotine Addiction Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Nicotine Addiction Global Clinical Trials Review, H1, 2015" provides data on the Nicotine Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nicotine Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nicotine Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Nicotine Addiction 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Nicotine Addiction to Central Nervous System Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Nicotine Addiction to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Nicotine Addiction 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Nicotine Addiction Therapeutics Clinical Trials 31

Prominent Drugs 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

Johnson & Johnson 34

Clinical Trial Overview of Johnson & Johnson 34

Pfizer Inc. 36

Clinical Trial Overview of Pfizer Inc. 36

GlaxoSmithKline plc 38

Clinical Trial Overview of GlaxoSmithKline plc 38

Nabi Biopharmaceuticals (Inactive) 39

Clinical Trial Overview of Nabi Biopharmaceuticals (Inactive) 39

Omeros Corporation 40

Clinical Trial Overview of Omeros Corporation 40

Star Scientific, Inc. 41

Clinical Trial Overview of Star Scientific, Inc. 41

Rock Creek Pharmaceuticals INC 42

Clinical Trial Overview of Rock Creek Pharmaceuticals INC 42

FORUM Pharmaceuticals Inc. 43

Clinical Trial Overview of FORUM Pharmaceuticals Inc. 43

Bioprojet SCR 44

Clinical Trial Overview of Bioprojet SCR 44

Clinical Trial Overview of Top Institutes / Government 45

National Institute on Drug Abuse 45

Clinical Trial Overview of National Institute on Drug Abuse 45

University of Pennsylvania 47

Clinical Trial Overview of University of Pennsylvania 47

Yale University 49

Clinical Trial Overview of Yale University 49

Mayo Clinic 50

Clinical Trial Overview of Mayo Clinic 50

Centre for Addiction and Mental Health 51

Clinical Trial Overview of Centre for Addiction and Mental Health 51

University of Wisconsin Madison 52

Clinical Trial Overview of University of Wisconsin Madison 52

Mclean Hospital 53

Clinical Trial Overview of Mclean Hospital 53

Massachusetts General Hospital 54

Clinical Trial Overview of Massachusetts General Hospital 54

Duke University 55

Clinical Trial Overview of Duke University 55

University of California, San Francisco 56

Clinical Trial Overview of University of California, San Francisco 56

Five Key Clinical Profiles 57

Appendix 79

Abbreviations 79

Definitions 79

Research Methodology 80

Secondary Research 80

About GlobalData 81

Contact Us 81

Disclaimer 81

Source 81

List of Figures

Nicotine Addiction Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Nicotine Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Nicotine Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Nicotine Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Nicotine Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Nicotine Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 80

List of Tables

Nicotine Addiction Therapeutics, Global, Clinical Trials by Region, 2015* 7

Nicotine Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Nicotine Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Nicotine Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Nicotine Addiction Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Nicotine Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Nicotine Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Nicotine Addiction Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Nicotine Addiction Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Nicotine Addiction Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Nicotine Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 34

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 36

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 38

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Nabi Biopharmaceuticals (Inactive), 2015* 39

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Omeros Corporation, 2015* 40

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Star Scientific, Inc., 2015* 41

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Rock Creek Pharmaceuticals INC, 2015* 42

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by FORUM Pharmaceuticals Inc., 2015* 43

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioprojet SCR, 2015* 44

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Drug Abuse, 2015* 45

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2015* 47

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2015* 49

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 50

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for Addiction and Mental Health, 2015* 51

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2015* 52

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2015* 53

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 54

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 55

Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Nicotine Addiction Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Nicotine Addiction, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com